Amgen (AMGN) shares outstanding: 540.9M
Amgen had 540.9M shares outstanding on Oct 29, 2026, up 0.5% from 538.5M a year earlier.
From Amgen's filings with the SEC · AMGN stock page
Amgen shares outstanding by year
#229 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 29, 2026 | 540.9M | +0% |
| Oct 30, 2025 | 538.5M | +0% |
| Oct 25, 2024 | 537.5M | +0% |
| Oct 26, 2023 | 535.2M | +0% |
| Oct 31, 2022 | 533.6M | – |
Shares outstanding of similar companies
Companies in the same industry as Amgen, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Recursion Pharmaceuticals | 622.8M | Oct 26, 2026 |
| Amgen | 540.9M | Oct 29, 2026 |
| Iovance Biotherapeutics | 462.7M | Oct 27, 2026 |
| Moderna | 404.6M | Oct 30, 2026 |
| Taysha Gene Therapies | 326.0M | Nov 12, 2026 |
| DBV Technologies | 314.4M | Oct 26, 2026 |
| Sana Biotechnology | 299.6M | Oct 29, 2026 |
Questions and answers
What is Amgen's shares outstanding?
Amgen had 540.9M shares outstanding on Oct 29, 2026, up 0.5% from 538.5M a year earlier.
Numbers as reported in Amgen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology